Sentences with phrase «of vaccine research»

«It's a fantastic new technique that's going to allow us to visualize the virus in tissues like we've never been able to before,» says immunologist Richard Koup, deputy director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland, who was not involved in the research.

The team was led by Barton Haynes, M.D., director of the Duke Center for HIV / AIDS Vaccine Immunology - Immunogen Discovery (CHAVI - ID) and the Duke Human Vaccine Institute, and John Mascola, M.D., director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Dr. Ronald Schultz, a veterinary immunologist at the forefront of vaccine research and chair of the University of Wisconsin's Department of Pathobiological Sciences states, «Vaccines for diseases like distemper and canine parvovirus, once administered to adult animals, provide lifetime immunity.»

In 2003 Claire became Head of the Department of Vaccine Research of NVI, where she coordinated and managed the Strategic Vaccine Research Program, designed to form a bridge between fundamental scientists in the field of microbiology, immunology, and vaccinology from (inter) national universities, biotech companies and / or vaccine institutes and NVI.

«The field of vaccine research intersects with areas of public health, economics, politics, ethics, and patent / intellectual property issues.

«When viruses are unavailable for work in the lab, that is really a downside,» says Larry Smith, vice president of vaccine research at Vical Inc. in San Diego.

«CMDR stands for Chiang Mai Double Recombinant,» according to Dr. Mary Marovich, Chief of the MHRP Department of Vaccine Research and Development.

Sitting at the nexus of vaccine research and manufacturing, she's charged with speeding commercialization of new shots and increasing the reach of existing ones.

He teamed up with Robert Seder of the Vaccine Research Center (VCR) at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, and scientists at other labs to test immune responses to the vaccine in animals.

Old paradigms are rapidly being reworked with virtually no area of vaccine research, vaccine development, clinical trials, vaccine deployment or policy left untouched.

The footprint of vaccine research has increased.

Currently, RV144 vaccine from Thailand is the only HIV preventive vaccine htat has shown efficacy in the last 30 years of vaccine research.

While Dr. Steinman wishes he had more time for both hobbies, he would like the emphasis of vaccine research to be more like the ballroom dance.

Vaccine Nation says the «Most Influential People in Vaccines» list was compiled after receiving hundreds of votes for those representing all sectors of the vaccine research industry.

She has been Science Director of the Global HIV Vaccine Enterprise, New York, and Director of the Division of B cell and mucosal immunity of the Vaccine Research Institute, Paris.

People have attempted to make vaccines for group B N. meningitidis over the years, but it has been literally impossible, according to Rino Rappuoli, Vice President of Vaccine Research for the Chiron Corporation, and an author on both Science papers.

Concurrently she is Head of Vaccine Research Unit, Department of Immunology at the University Hospital and Head of Division of Infectious and Inflammatory Diseases, deCODE genetics, Reykjavik.

1994 saw her as Head of the Department of Transplantation Immunology at the CLB, in Amsterdam, and in 1999 she became Head of the department of the Immunology of the Laboratory of Vaccine Research of the National Institute of Public Health and Environmental Protection (RIVM), in Bilthoven, where her research activities focused on defining immunological correlates of protection on the T and B cell level after natural infection and vaccination.

Now that I am part of a Vaccine Research Center (VRC) vaccine study, it enhances that altruistic feeling even more, knowing that my participation may someday save millions of lives.

Nanotheraputics for Antibiotic Resistent Emerging Bacterial pathogens (NAREB) European Research Infrastructures for Poverty Related Diseases (EURIPED) Biomarkers for enhanced vaccines immunosafety (BioVacSafe) European network of vaccine research and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBVAC2020)

In the Duration of Immunity to Canine Vaccines: What We Know and What We Don't Know, Proceedings — Canine Infectious Diseases: From Clinics to Molecular Pathogenesis, Ithaca, NY, 1999, Dr Ronald Schultz, a veterinary immunologist at the forefront of vaccine research and chair of the University of Wisconsin's Department of Pathobiological Sciences, outlines the duration of immunity for the following vaccines:

«It's a nice tool to have in our arsenal,» says virologist Gary Nabel, director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland.

Although, the efficacy is not much, it provide s a glimmer of hope for scientists working in the field of vaccine research.

«These vaccines are preventative and work like other vaccines that prevent diseases caused by viruses and bacteria: they prompt the body to produce antibodies to protect against infection,» Marion Gruber, director of the FDA's Office of Vaccines Research and Review, said in the news release.

However, widespread vaccination «is going to be hard to justify,» argues Gary Nabel, director of the Vaccine Research Center at the National Institutes of Health in Bethesda, Md..

«We may be able to create a ring of vaccination around an outbreak to contain it,» says Gary Nabel, of the Vaccine Research Center at the National Institutes of Health near Washington DC, who led the new research.

He was chief of Microbiology and Immunology and of Vaccine Research and Development at the World Health Organization and was deeply involved in the coordination of research aiming at the development of vaccines against diseases of major importance.

Geels M, Thøgersen RL, Guzman CA, Ho MM, Verreck F, Collin N, Robertson JS, McConkey SJ, Kaufmann SH, Leroy O. TRANSVAC research infrastructure - Results and lessons learned from the European network of vaccine research and development.

He previously served as Executive Director of Vaccine Research and Head of Department of Vaccine Basic Research at Merck Research Laboratories, a pharmaceutical company, from April 2008 to September 2013.

The Statens Serum Institut (SSI), Vaccine Development Department (VUA) and Center of Vaccine Research (CVR), Copenhagen, Denmark, is internationally recognised for its vaccine research and clinical pipeline.